UNSPSC 51284018: Chlortetracycline bisulfate

This classification denotes a tetracycline antibiotic with the molecular formula C22H23ClN2O8.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1D06KZ672I, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but more generally known as chlortetracycline bisulfate, which bears US NIH Compound Identifier 5280963. Most nations, for tariff and trade purposes, schedule chlortetracycline bisulfate under HS 29413000 and SITC 54133.

As of Q4 2014, CHLORTETRACYCLINE BISULFATE remains US FDA's Preferred Term for this commodity. Chlortetracycline bisulfate bears US NLM identifiers UMLS ID C0282101 and NCI Concept Code C76989. SMILES: C[C@]1(C2C(CCC(C2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)CL)O.OS(=O)(=O)O.

UNSPSC 51284018 Chlortetracycline bisulfate is a Commodity code showing little relevant recent activity. The recent state and local opportunities tagged under this code are being solicited for naloxone, medical and first aid supplies, generic pharmaceuticals, and direct-to-manufacturer prescription programs — none of which are chlortetracycline bisulfate or veterinary-grade tetracycline products. The mismatch between the code's nominal scope (a specific antibiotic compound) and the actual procurements being tagged suggests either systematic miscoding or that state and local jurisdictions are not actively buying chlortetracycline bisulfate through standard UNSPSC-classified solicitations at present.

The issuing bodies in the recent-opportunity block span county and city health departments (Seminole County, Florida; City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across Minnesota and Oregon). However, none of these procurements target the commodity named in the code. The geographic spread covers Florida, Texas, and Minnesota-Oregon, but this geographic distribution reflects the unrelated opportunities that have been miscoded rather than genuine demand for chlortetracycline bisulfate. A business development professional evaluating this code should verify whether state and local procurement activity for chlortetracycline bisulfate exists outside the tagged opportunities or whether the code tier and scope require clarification.